Experimental pain med could give patients new option to opioids
The first new kind of pain medication in over two decades could be on the horizon for patients, with promising results announced Tuesday from a company trial.
Jan 30, 2024
0
0
The first new kind of pain medication in over two decades could be on the horizon for patients, with promising results announced Tuesday from a company trial.
Jan 30, 2024
0
0
In humans, oral health influences general health and well-being in many ways. Other than reducing the need for oral rehabilitation later in life, maintaining good oral health reduces the risk of several systemic diseases. ...
Jan 30, 2024
0
11
For patients with embolization-eligible unresectable hepatocellular carcinoma (uHCC), the addition of durvalumab (D) and bevacizumab (B) to transarterial chemoembolization (TACE) improves progression-free survival (PFS), ...
Jan 29, 2024
0
0
A higher level of maternal autistic traits is associated with an increased risk for adverse birth outcomes, according to a study published online Jan. 23 in JAMA Network Open.
Jan 26, 2024
0
0
A study led by University of California, Irvine researchers has revealed a connection between blood levels of omega-3 and the inflammatory biomarker interleukin-8 and greater chemotherapy-related gastrointestinal symptoms ...
Jan 24, 2024
0
0
Walking limitation is significantly associated with five-year fracture risk, according to a study published online Jan. 23 in JAMA Network Open.
Jan 24, 2024
0
0
COVID-19 vaccination during pregnancy seems safe in terms of neurodevelopment through 18 months of age, according to a study published online Jan. 22 in JAMA Pediatrics.
Jan 24, 2024
0
1
The Massachusetts state Senate voted unanimously to legalize fentanyl test strips across the commonwealth earlier this month. The paper indicators had been considered illegal drug paraphernalia as they could be used to test ...
Jan 23, 2024
0
0
Control of dyslipidemia and diabetes, but not hypertension, reduces the association of HIV status with cardiovascular disease (CVD), according to a study published online Jan. 16 in Clinical Infectious Diseases.
Jan 22, 2024
0
1
Purdue University researchers have taken the first steps to treat Alzheimer's disease, Parkinson's disease and Type 2 diabetes by creating multiple patent-pending compounds shown to inhibit protein aggregation associated ...
Jan 19, 2024
0
21